JPRN-UMIN000022185已完成未知
Analysis on response to darbepoetin alfa in patients with low risk myelodysplastic syndromes - Myelodysplastic syndrome 01 study in West Japan Hematology Study Group (W-JHS MDS01 study)
Cooperative study between the West Japan Hematology Study Group and Clinical Research Support Center Kyushu0 个研究点目标入组 85 人开始时间: 2016年5月9日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 85
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients at risk of thromboembolism with present or past medical history of myocardial infarction, pulmonary infarction and cerebral infarction or similar disorders. 2) Patients with uncontrollable hypertension. 3) Patients with medical history of drug hypersensitivity to darbepoetin alfa or other erythropoietin formulation. 4) Patients with severe (need for hospital care, or judgement by investigators) or uncontrollable complication. 5) Patients inappropriate for study participation due to complication of mental disease or psychiatric symptom. 6) Patients with cognitive disorder. 7) Patients judged by investigators to be inappropriate for study participation.
研究者
相似试验
已完成
不适用
The effect of intervention with darbepoetin alfa on progression of renal decline[chronic renal failure?] in renal anaemia patients with chronic kidney disease not on dialysis.renal anaemia patients with chronic kidney disease not on dialysisJPRN-UMIN000006963Division of Nephrology,Department of Internal Medicine,Juntendo University Faculty of Medicine200
尚未招募
2 期
Phase II study of the addition of darbepoetin alfa (Aranesp) and pegfilgrastim (Neulasta) support for optimal dose-dense chemotherapy for early breast cancerCancer - BreastBreast CancerACTRN12605000731695Mater Adult hospital30
进行中（未招募）
不适用
Evaluation of the Efficacy of Darbepoetin Alfa for the Treatment of Anemia in Patients with Myelodysplastic Syndrome - DARB-MDSEUCTR2005-004737-17-ITAZIENDA OSPEDALIERA BIANCHI-MELACRINO-MORELLI54
已完成
不适用
Effect of darbepoetin alfa on quality of life in anemia of chronic kidney disease elderly patients with type 2 diabetes mellitusRenal anemia with type 2 diabetes mellitusJPRN-UMIN000007693Graduate School of Medicine, Chiba University12
进行中（未招募）
不适用
A Randomized Open-Label Study of Darbepoetin alfa Administered Every Three Weeks with or without Parenteral Iron in Anemic Subjects with Nonmyeloid Malignancies Receiving ChemotherapyEUCTR2004-001417-33-ITAMGE